Celldex Therapeutics reported $32.96M in Current Liabilities for its fiscal quarter ending in June of 2025.


Current Liabilities Change Date
AbbVie USD 36.4B 2.35B Mar/2025
Amgen USD 20.48B 2.53B Jun/2025
Bristol-Myers Squibb USD 27.53B 3.46B Jun/2025
Celldex Therapeutics USD 32.96M 945K Jun/2025
Glaxosmithkline GBP 20.38B 1.32B Jun/2025
Pfizer USD 37.73B 1.27B Jun/2025
Roche Holding CHF 27.02B 424M Dec/2024